COTI-2 Receives Favourable Independent Pre-Investigational New Drug Gap Analysis Report
Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced today that it received a favourable Pre-Investiga…
Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced today that it received a favourable Pre-Investiga…
Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) is pleased to announce that it has accepted an invitation f…